Research

Driving Innovation

Investigation into the role of iron in human diseases and how to use iron chelators to treat conditions created or worsened by iron is a major research area of ApoPharma’s. Our research includes conditions with generalized iron overload such as in patients who have repeated blood transfusions, as well as conditions where there is no generalized iron overload, only localized regions of slightly elevated iron or even intracellular mishandling of iron, leading to iron-induced pathology, including certain neurological disorders, such as Friedreich Ataxia, pantothenate kinase associated neurodegeneration and Parkinson's Disease.

ApoPharma is also conducting research on novel approaches to treat certain immune-related disorders, including psoriasis. While there are many treatments available for such conditions, some are effective for only brief periods of time, or carry the risk of serious adverse events related to the actions of such agents on modulation of physiologic processes related to infection and control of malignant cells. By looking for unique targets to modify conditions such as psoriasis, it may be possible to treat the condition, without putting patients at risk of serious side effects.

Learn about ongoing clinical studies at ClinicalTrials.gov.

Leaving ApoPharma.com

You are now leaving ApoPharma Inc. This link will take you to a web site where this site’s Privacy Policy does not apply. You are solely responsible for your interactions with that web site. We encourage you to read the privacy policy of every Web site you visit.

CONTINUE RETURN TO APOPHARMA.COM

Leaving ApoPharma.com

You have expressed an interest in looking at job openings for ApoPharma Inc. You are now leaving the ApoPharma website and entering the Apotex website. Do not be concerned, ApoPharma is a part of the Apotex group of companies. All job openings for Apotex member companies, including those for ApoPharma Inc. are found on this website.

CONTINUE RETURN TO APOPHARMA.COM